J. Daniel Shaughnessy
Us Myasthenia Gravis Indication Marketing Lead @argenx
Signup · Get unlimited contacts
WORK HISTORY
Us Myasthenia Gravis Indication Marketing Lead @argenx
Boston, MA, US
Exceeded 2023 MG Indication revenue expectationsLead HCP marketing team, Personal, Non-Personal, and Digital promotional channelsLed the development and execution of the second product launch for argenx, VYVGART HytruloLed the 2024 MG brand planning process and strategy developmentResponsible for providing guidance and leadership in the US organizations pivot to a novel operating model
EDUCATION
Western New England University
BSBA, Marketing
Plymouth State University
MBA, Business Administration
ABOUT J. DANIEL SHAUGHNESSY
Consistently creates partnerships across an organization that drive results, builds corporate culture and endeavors to improve patients lives• Experiences span the product lifecycle, including product launches, as well as strategy development through tactical execution at the US and Global levels, strong team leadership, addressing unique challenges and driving commercial success• Professional leadership experiences in:• US HCP, Patient, Key Account, and Franchise marketing• Global marketing• Field team leadership with Sales, Nurse Educator, and Disease Educator teams• Key therapeutic areas of experience are: Hematology/Oncology, Endocrinology (Rare Disease), Neurology (Specialty), Antiviral/Transplant (Rare Disease), Anti-Infectives, RespiratoryCan lead in the following roles:*Head of Sales*Head of Marketing*Commercial Operations Leader
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.